DNALite Therapeutics

DNALite Therapeutics is developing gene therapy treatments for the gastrointestinal tract. The first lead candidate is for colon cancer, which is the second deadliest cancer in the U.S.

Be Part of the Revolution!

Next program starts Winter 2017. Early applications due July 30th!